Upcoming conference on cell therapy

The Cardiovascular Research Foundation is bringing experts to New York City from around the world for the Third Annual International Conference on Cell Therapy for Cardiovascular Diseases. The conference is schedule to run from January 17 to 19. Release

Suggested Articles

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.